An innovative service company focusing on the field of drug quality control

News

Contact Us

You are here:Home >> News >> Company News

Company News

Trelagliptin- 2 diabetes mellitus

Time:2023-05-12 Views:168
Trelagliptin is a dipeptidyl peptidase-4 inhibitor indicated in the treatment of type 2 diabetes mellitus (T2DM). To support your analysis and help ensure the accuracy of quality processes, we supply a range of Trelagliptin -related impurities standards with certified COA and characterization data like Mass, HPLC, NMR & TGA report.
The following are some of the impurities of Trelagliptin :
  • Previous:Lincomycin Impurity  2024/11/18
  • Next:Fenofibrate Impurities - SZEB  2023/05/06